Target intelligence / Profile preview

Frataxin pseudogene 1 (FXNP1)

Target
FXNP1
Molecular classification
Other (Pseudogene)
01

Overview

Frataxin pseudogene 1 (FXNP1) is a genomic DNA sequence similar to the functional frataxin gene (FXN), but lacks the ability to produce protein due to mutations or deletions that disrupt the coding region. Genuine frataxin (produced by the FXN gene) is crucial for mitochondrial iron-sulfur cluster biosynthesis, and mutations in the FXN gene cause Friedreich's ataxia, a neurodegenerative disease[1][5][3]. However, FXNP1 does not encode a protein, has no known biological function, and is not a receptor, enzyme, transporter, or other druggable target. It should not be used as a target in therapeutic research or biomarker development. Clarification: If your intention was to refer to the functional frataxin gene/protein (FXN) rather than FXNP1, please specify, as FXN is a well-established mitochondrial protein implicated in energy metabolism and Friedreich's ataxia[3][1][5][4]. FXNP1, as a pseudogene, should be excluded from structured drug target databases and resources.

Other names
FXNP1

Beyond the preview

Go deeper on Frataxin pseudogene 1 (FXNP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frataxin pseudogene 1 (FXNP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call